Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cardiovascular system homeostasis encompasses the dynamic balance maintained by neural reflexes, endocrine signals, local autoregulatory mechanisms, cellular interactions within the heart and vessels ensuring adequate tissue perfusion under varying physiological conditions. Key neural components include baroreceptors sensing blood pressure changes and chemoreceptors monitoring oxygen/carbon dioxide/pH levels that relay information centrally to adjust cardiac output and vascular resistance accordingly. Endocrine factors such as epinephrine/norepinephrine released during stress increase heart rate/contractility while hormones like angiotensin II regulate fluid balance through vasoconstriction/sodium retention. At the cellular level within the heart are cardiomyocytes responsible for pumping action whose gene expression programs adapt during stress states. Immune cells resident in cardiac tissues contribute both to normal physiology—such as electrical conduction—and pathological remodeling after injury. The renin–angiotensin–aldosterone system plays a pivotal role in long-term blood pressure regulation with angiotensin II acting mainly through its G protein-coupled AT1 receptor inducing hypertrophic responses when overstimulated. Overall this integrated network ensures stable internal environment despite external fluctuations—termed “homeostasis”—critical for survival. Disruption leads to diseases including hypertension, ischemia-related damage, arrhythmias,and chronic heart failure.
Mechanisms by which drugs modulate cardiovascular homeostatic pathways include: Inhibition/blockade of angiotensin II type 1 receptor reducing vasoconstriction and sodium retention; Beta-adrenoceptor blockade reducing heart rate/cardiac output via sympathetic inhibition; Enhancement or mimicry of nitric oxide signaling causing vasodilation. These drugs act on specific receptors or enzymes that regulate cardiovascular function but do not target "cardiovascular system homeostasis" per se.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiovascular System Homeostasis (None).